Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M610925200 on April 19, 2007

J. Biol. Chem., Vol. 282, Issue 26, 18864-18871, June 29, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/26/18864    most recent
M610925200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steen, M.
Right arrow Articles by Guse, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steen, M.
Right arrow Articles by Guse, A. H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

NAADP Mobilizes Calcium from the Endoplasmic Reticular Ca2+ Store in T-lymphocytes*

Mareike Steen1, Tanja Kirchberger, and Andreas H. Guse2

From the Calcium Signaling Group, University Medical Centre Hamburg-Eppendorf, Centre of Experimental Medicine, Institute of Biochemistry and Molecular Biology I, Cellular Signal Transduction, Martinistrasse 52, D-20426 Hamburg, Germany

Received for publication, November 27, 2006 , and in revised form, April 19, 2007.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The target calcium store of nicotinic acid adenine dinucleotide phosphate (NAADP), the most potent endogenous calcium-mobilizing compound known to date, has been proposed to reside in the lysosomal compartment or in the endo/sarcoplasmic reticulum. This study was performed to test the hypothesis of a lysosomal versus an endoplasmic reticular calcium store sensitive to NAADP in T-lymphocytes. Pretreatment of intact Jurkat T cells with glycyl-phenylalanine 2-naphthylamide largely reduced staining of lysosomes by LysoTracker Red and abolished NAADP-induced Ca2+ signaling. However, the inhibitory effect was not specific since Ca2+ mobilization by D-myo-inositol 1,4,5-trisphosphate and cyclic ADP-ribose was abolished, too. Bafilomycin A1, an inhibitor of the lysosomal H+-ATPase, did not block or reduce NAADP-induced Ca2+ signaling, although it effectively prevented labeling of lysosomes by LysoTracker Red. Further, previous T cell receptor/CD3 stimulation in the presence of bafilomycin A1, assumed to block refilling of lysosomal Ca2+ stores, did not antagonize subsequent NAADP-induced Ca2+ signaling. In contrast to bafilomycin A1, emptying of the endoplasmic reticulum by thapsigargin almost completely prevented Ca2+ signaling induced by NAADP. In conclusion, in T-lymphocytes, no evidence for involvement of lysosomes in NAADP-mediated Ca2+ signaling was obtained. The sensitivity of NAADP-induced Ca2+ signaling toward thapsigargin, combined with our recent results identifying ryanodine receptors as the target calcium channel of NAADP (Dammermann, W., and Guse, A. H. (2005) J. Biol. Chem. 280, 21394–21399), rather suggest that the target calcium store of NAADP in T cells is the endoplasmic reticulum.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Nicotinic acid adenine dinucleotide phosphate (NAADP)3 was discovered by Lee et al. (1) as endogenous nucleotide with Ca2+-mobilizing properties. In comparison with the Ca2+-mobilizing second messengers D-myo-inositol 1,4,5-trisphosphate (InsP3) and cyclic ADP-ribose (cADPR) that require micromolar concentrations for activity in mammalian cells (2, 3), NAADP acts at low nanomolar concentrations and displays a bell-shaped concentration-response curve in many different eukaryotic cell types (4–6). Although InsP3 and cADPR are firmly established as second messengers, receptor-mediated formation of NAADP has yet been shown in a limited number of cellular systems only (7–9).

The search for the target organelle and the molecular receptor for NAADP has attracted much attention in the last years. Lee et al. (10) demonstrated different subcellular localizations of the NAADP-sensitive Ca2+ pool versus the InsP3- and cADPR-sensitive Ca2+ pools in stratified sea urchin eggs. This NAADP-sensitive Ca2+ pool was identified as the reserve granule in sea urchin eggs, an organelle related to lysosomes (11). In addition, pharmacological and partial biochemical characterization suggests expression of a novel NAADP receptor/Ca2+ channel in sea urchin eggs (1, 12–15).

In a few higher eukaryotic cell types, evidence for the involvement of ryanodine receptors (RyR) in NAADP-mediated Ca2+ signaling has been published. NAADP activated purified RyR from heart and skeletal muscle in lipid planar bilayers (16, 17). In addition, NAADP-induced Ca2+ release from the nuclear envelope of pancreatic acinar cells and from permeabilized pancreatic acinar cells was blocked by RyR antagonists (18, 19).

In human Jurkat T-lymphocytes, we have demonstrated: (i) TCR-CD3-mediated formation of NAADP (9), (ii) Ca2+ signaling induced by microinjection of NAADP in a concentration-dependent fashion (6), (iii) that NAADP-induced Ca2+ signaling consists of both Ca2+ release and Ca2+ entry (6, 20), and (iv) involvement of RyR in both local and global Ca2+ signaling (20, 21). Here we confirm that lysosomes can be functionally destroyed using either hypertonic swelling and physical destruction by glycyl-phenylalanine 2-naphthylamide (GPN) or inhibition of the lysosomal H+-ATPase using bafilomycin A1 (11). Although GPN pretreatment resulted in loss of Ca2+-mobilizing activity of all three second messengers, NAADP, cADPR, and InsP3, there was no inhibitory effect of bafilomycin A1 on any of the Ca2+-mobilizing compounds, even when endogenous Ca2+ stores were previously emptied by TCR-CD3 stimulation in the presence of bafilomycin A1. In contrast, emptying the endoplasmic reticular (ER) Ca2+ store by thapsigargin almost completely prevented Ca2+ signaling induced by NAADP. Taken together, our data indicate a major role for the ER, but not for lysosomes, in NAADP-mediated Ca2+ signaling in T cells.


Figure 1
View larger version (36K):
[in this window]
[in a new window]

  		FIGURE 1.
Effect of GPN on LysoTracker (Lyso) staining of lysosomes and on Ca2+ release by NAADP, InsP3 and cADPR in intact Jurkat T-lymphocytes. The effect of GPN on the intensity of LysoTracker staining is shown in A, panels I and II; the cell border is indicated by the dashed line (A, panel II). Jurkat T cells were loaded with LysoTracker Red (75 nM) and incubated with GPN (50 µM) or cathepsin inhibitor 1 (C1–1, 50 µM) plus GPN (10 µM), respectively. Vehicle (Me2SO (DMSO) 0.1% v/v and 0.2% v/v) was used as control. B–D, Jurkat T cells were loaded with Fura-2 and subjected to combined Ca2+ imaging and microinjection as detailed under "Experimental Procedures." Time points of the start of incubation and microinjection are indicated by arrows. Cells were incubated with GPN (50 µM) or with Me2SO (0.1% v/v) as control and microinjected with 100 nM NAADP (B), 4 µM InsP3 (C) or 100 µM cADPR (D), respectively. Data were synchronized and represent mean values.

 

   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Materials—NAADP, GPN, GdCl3, and bafilomycin A1 (lot 1) were supplied from Sigma-Aldrich (Deisenhofen, Germany). cADPR was obtained from Biolog (Bremen, Germany). Fura-2/AM, bafilomycin A1 (lots 2 and 3), cathepsin inhibitor 1, and thapsigargin were purchased from Calbiochem. InsP3 was from Biomol (Hamburg, Germany). The anti-CD3 mouse monoclonal antibody OKT3 was purified from hybridoma supernatant on protein G-Sepharose FF (GE Healthcare, Freiburg, Germany). LysoTracker Red DND-99 was obtained from Molecular Probes (Leiden, The Netherlands).

Cell Culture—Jurkat T-lymphocytes (subclone JMP) were cultured as described previously (22).

Ratiometric Ca2+ Imaging—The cells were loaded with Fura-2/AM as described (22) and kept in the dark at room temperature until use. Thin glass coverslips (0.1 mm) were coated first with bovine serum albumin (5 mg/ml) and subsequently with poly-L-lysine (0.1 mg/ml). Silicon grease was used to seal small chambers consisting of a rubber O-ring on the glass coverslip. Then, 60 µl of buffer A containing 140 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 1 mM Na2HPO4, 5.5 mM glucose, and 20 mM HEPES (pH 7.4), and 40 µl of cell suspension (2 x 106 cells/ml) suspended in the same buffer were added into the small chamber (6), and the coverslip was mounted on the stage of a fluorescence microscope (Leica DMIRE2). In some experiments, GdCl3 (10 or 100 µM) was added to buffer A to block capacitative Ca2+ entry; in these experiments, buffer A without Na2HPO4 was used to prevent precipitation of GdPO4.

Ratiometric Ca2+ imaging was performed as described recently (23). We used an Improvision imaging system (Tübingen, Germany) build around the Leica microscope at 100-fold magnification. Illumination at 340 and 380 nm was carried out using a monochromator system (Polychrom IV, TILL Photonics, Gräfelfing, Germany). Images were taken with a gray-scale CCD camera (type C 4742-95-12ER; Hamamatsu, Enfield, United Kingdom) operated in 8-bit mode. The spatial resolution was 512 x 640 pixels at 100-fold magnification. Camera exposure times were 12 ms (at 340 nm) and 4 ms (at 380 nm). The acquisition rate was adjusted to ~14 ratios/min. Raw data images were stored on a hard disk. Confocal Ca2+ images were obtained by off-line deconvolution (no-neighbor algorithm) using the volume deconvolution module of the Openlab software as described recently for 3T3 fibroblasts (24). The deconvolved images were used to construct ratio images (340/380 nm) pixel by pixel. Finally, ratio values were converted into Ca2+ concentrations by external calibration (23). Data processing was performed using Openlab software, version 3.0.8 or 1.7.8 (Improvision).

Microinjection—Microinjections were carried out as described (25). We used an Eppendorf system (transjector type 5246, micromanipulator type 5171, Eppendorf-Netheler-Hinz, Hamburg, Germany) with Femtotips I and II as pipettes. NAADP, InsP3, or cADPR were diluted to their final concentration in intracellular buffer (20 mM HEPES, 110 mM KCl, 10 mM NaCl, pH 7.2) and filtered (0.2 µm) before use. Injections were made using the semiautomatic mode of the system with following instrumental settings: injection pressure 60–90 hectopascals, compensatory pressure 30–50 hectopascals, injection time 0.3–0.5 s, and velocity of the pipette 700 µm/s.


Figure 2
View larger version (39K):
[in this window]
[in a new window]

  		FIGURE 2.
Effect of bafilomycin A1 (Baf) on LysoTracker staining (Lyso) of lysosomes and on Ca2+ release by NAADP in intact Jurkat T-lymphocytes. The effect of bafilomycin A1 on the intensity of LysoTracker staining is shown in A, panels I and II; the cell border is indicated by the dashed line (A, panel II). Jurkat T-lymphocytes were preincubated with different concentrations of bafilomycin A1 and Me2SO (DMSO) (0.1% v/v) as control and loaded with LysoTracker Red as described under "Experimental Procedures." Data are mean ± S.E. (n = 33–84). Three different lots of bafilomycin A1 were used for experiments and were analyzed by RP-HPLC as described under "Experimental Procedures" (B). C–F, Jurkat T cells were loaded with Fura-2, and combined Ca2+ imaging and microinjections were carried out as described under "Experimental Procedures." The time points of microinjections are indicated by arrows. Cells were preincubated with Me2SO (0.1%, C) or with different concentrations of bafilomycin A1 and microinjected with 100 nM NAADP. In D, cells were preincubated with 12.5 nM bafilomycin A1 (lot 1); in E, cells were preincubated with 250 nM (lot 3); and in F, cells were preincubated with 1000 nM (lot 3) bafilomycin A1. Combined data are shown in G; data are mean values ± S.E. from the time points 40–65 (Ca2+ peak) or 400 s (Ca2+ plateau).

 


Figure 3
View larger version (39K):
[in this window]
[in a new window]

  		FIGURE 3.
Effect of bafilomycin A1 (Baf) on Ca2+ release by InsP3 and cADPR in intact Jurkat T-lymphocytes. A–D, Jurkat T cells were loaded with Fura-2 and subjected to combined Ca2+ imaging and microinjection as detailed under "Experimental Procedures." The time points of microinjections are indicated by arrows. Cells were preincubated with Me2SO (DMSO) (0.1% v/v, A and C) or 12.5 nM bafilomycin A1 (B and D) and microinjected with 4 µM InsP3 (A and B) or 100 µM cADPR (C and D).

 
Staining of Lysosomes—Lysosomes were labeled by incubation of cells with 75 nM LysoTracker Red DND-99 for 30 min at room temperature. Cells were added into small chambers (see above), and fluorescence was determined at excitation and emission wavelengths of 575 and 590 nm using the Improvision imaging system as described above.

Then, cells were treated either with 50 µM GPN, 10 µM cathepsin inhibitor 1, plus 50 µM GPN or with Me2SO (0.1% v/v or 0.2% v/v) for 15 min at room temperature. To analyze the effect of bafilomycin A1 on LysoTracker staining, untreated cells were incubated with different concentrations of bafilomycin A1 or 0.1% v/v Me2SO as control for 15 min at room temperature, and afterward, lysosomes were labeled with Lyso-Tracker Red DND-99 as described above (26).

HPLC Analysis of Bafilomycin A1—RP-HPLC analysis of bafilomycin A1 was performed on a 250 x 4.6-mm Multohyp BDS C18-5µ column (CS Chromatographie Service, Langerwehe, Germany) equipped with a 4.0 x 3.0-mm guard cartridge containing a C18 (ODS) filter element (Phenomenex, Aschaffenburg, Germany). The separation was performed at a flow rate of 1 ml/min with phosphate buffer (20 mM KH2PO4, pH 6) containing increasing amounts of methanol. The gradient used for separation was as follows (number in parentheses represents the percentage of methanol): 0 min (5), 2 min (5), 16 min (100), 20 min (100), 22 min (5), 25 min (5). Bafilomycin A1 was detected using a Diode Array Detector (Agilent, Santa Clara, CA) at 246 nm.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
To analyze whether in Jurkat T-lymphocytes lysosomes represent a Ca2+ store sensitive to NAADP, we treated intact cells with GPN, a substrate of cathepsin C. Via osmotic lysis, the metabolic products of GPN selectively disrupt lysosomal membranes (11, 27). The resulting significant loss of lysosome staining by LysoTracker Red was confirmed in Jurkat T cells (Fig. 1A). GPN increased the intracellular Ca2+ concentration by lysing the lysosomes (Fig. 1, B–D, right panels). As described for sea urchin eggs (11), GPN also abolished NAADP-mediated Ca2+ release in T cells (Fig. 1B, right panel). However, Ca2+ release by InsP3 or cADPR was eliminated, too (Fig. 1, C and D, right panels). Therefore, we used cathepsin inhibitor 1, which is known to reduce the damaging effect of GPN by inhibition of cathepsin B, L, and S and also papain released from the lysosomes. Since cathepsin inhibitor 1 does not inhibit cathepsin C, the disruption of lysosomes by GPN should be unaffected (19). This was indeed confirmed since the intensity of lysosomes labeled with LysoTracker Red after incubation with cathepsin inhibitor 1 (10 µM) plus GPN (50 µM) was reduced similarly as compared with the control (Fig. 1A). However, treatment with cathepsin inhibitor 1 and GPN not only blocked NAADP-mediated Ca2+ release, but also, Ca2+ release by InsP3 or cADPR was abolished in Jurkat T-lymphocytes (data not shown) as shown above for GPN alone. Thus, although GPN appears to be a powerful tool to destroy lysosomes, the release of lysosomal proteases or other hydrolases seems to interfere with all Ca2+ release systems present in T cells. Since cADPR and InsP3 are supposed to target the ER, the data obtained with GPN do not allow a clear-cut decision as to whether NAADP solely acts on lysosomes.

As a second approach, we investigated the effect of bafilomycin A1 on global Ca2+ signals induced by NAADP. Bafilomycin A1 is an inhibitor of vacuolar H+-pumps powered by ATP (28), prevents organelle acidification, and blocks the Ca2+ reuptake into lysosomes via Ca2+/H+-exchanger since this transport protein requires a proton gradient (11). As LysoTracker Red DND-99 is a weak base and accumulates in acidic compartments, preincubation with bafilomycin A1 concentration-dependently reduced or abolished labeling of lysosomes with LysoTracker Red DND-99 (26), a result that was confirmed in Jurkat T cells (Fig. 2A). For our experiments, we used different lots of bafilomycin A1 purchased from different suppliers. Identity, purity, and content were confirmed by HPLC (Fig. 2B). Then, cells were preincubated with increasing concentrations of bafilomycin A1 or vehicle (Me2SO 0.1% v/v) and microinjected with 100 nM NAADP (Fig. 2, C–G). No reduction of NAADP-mediated Ca2+ signaling was observed after preincubation with bafilomycin A1 at concentrations up to 1 µM (Fig. 2, C–G). In contrast, a slight increase of the NAADP-mediated Ca2+ peak at 250 nM bafilomycin A1 was detected as compared with the control (Fig. 2, E and G). Bafilomycin A1 at a concentration that almost completely abolished the lysosome H+ gradient did not affect InsP3- or cADPR-mediated Ca2+ signaling (Fig. 3). Since InsP3 and cADPR have been shown to release Ca2+ from the ER, this control experiment suggests that bafilomycin A1, in contrast to GPN (Fig. 1), in principle can be used to analyze the role of lysosomes in T cell Ca2+ signaling.


Figure 4
View larger version (36K):
[in this window]
[in a new window]

  		FIGURE 4.
Effect of bafilomycin A1 (Baf) on NAADP-mediated Ca2+ signaling in intact Jurkat T-lymphocytes previously stimulated via the TCR-CD3 complex. A–D, Jurkat T cells were loaded with Fura-2 and subjected to combined Ca2+ imaging and microinjection as detailed under "Experimental Procedures." The time points of OKT3 additions and microinjections are indicated by arrows; the time points of microinjections were synchronized. Cells were preincubated with Me2SO (DMSO) (0.1% v/v, A) or with different concentrations of bafilomycin A1, stimulated by the addition of OKT3 (10 µg/ml) and microinjected with 100 nM NAADP. In B, cells were preincubated with 12.5 nM bafilomycin A1 (lot 1); in C, cells were preincubated with 250 nM (lot 3); and in D, cells were preincubated with 1000 nM (lot 3) bafilomycin A1. Combined data are shown in E; data represent mean values ± S.E. from the time points 415–450 (NAADP-mediated Ca2+ peak) or 800 s (NAADP-mediated Ca2+ plateau).

 
Lysosomes are supposed to be very tight Ca2+ stores, with almost no passive leak of Ca2+ ions into the cytosol (11). In Jurkat T-lymphocytes, TCR-CD3 stimulation is known to increase intracellular NAADP levels (9). If lysosomes are the organelles targeted by NAADP, stimulation via the TCR-CD3 complex in the presence of bafilomycin A1 should lead to Ca2+ depletion of lysosomal stores. As bafilomycin A1 inhibits the Ca2+ reuptake in lysosomes, a second increase of the NAADP level via microinjection should show a reduced or abolished NAADP-mediated Ca2+ release. However, Ca2+ signaling by NAADP after preincubation with bafilomycin A1 and subsequent stimulation via TCR-CD3 was not different from untreated controls, indicating no major role for bafilomycin A1-sensitive compartments in NAADP-mediated Ca2+ signaling (Fig. 4).

Since no evidence for an involvement for lysosomes in NAADP-induced Ca2+ signaling was obtained, the alternative hypothesis (the ER as NAADP-sensitive Ca2+ stores) was taken into account. Although the specific inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+ ATPases (SERCA), thapsigargin (29), is an effective and specific tool to deplete ER/SR-type Ca2+ stores, in intact, electrically non-excitable cells, there is often the problem of capacitative Ca2+ entry being switched on immediately (30, 31). Thus, to avoid any effects of capacitative Ca2+ entry, all further experiments were conducted in the presence of GdCl3 in the extracellular buffer. Under these conditions, microinjection of 100 nM NAADP resulted in transient elevations of [Ca2+]i with most of the cells returning to basal values within a few hundred seconds (Fig. 5A). Also, the mean amplitude of the initial peak induced by NAADP was significantly decreased in the absence of Ca2+ entry (compare Fig. 5A, right panel, with Fig. 2C, right panel). Thapsigargin also induced a transient elevation of [Ca2+]i, indicating rapid depletion of the ER and no concomitant activation of capacitative Ca2+ entry (Fig. 5B). A second activation of thapsigargin confirmed that the ER Ca2+ stores have indeed been depleted (Fig. 5B). Then, ER Ca2+ stores were depleted by thapsigargin, and NAADP was subsequently microinjected (Fig. 5C); almost none of the cells responded to NAADP (7 out of 9 cells). In a complimentary approach, the intracellular store sensitive to NAADP was partially depleted by microinjection of NAADP in the presence of GdCl3; then, the filling states of both the ER and the lysosomes were analyzed by the addition of either thapsigargin or GPN (Fig. 6). When compared with controls (injections of intracellular buffer instead of NAADP), the filling state of the ER was decreased slightly (Fig. 6, A, B, and E), whereas the content of the lysosomal store was unaffected (Fig. 6, C–E), indicating that NAADP releases Ca2+ from the ER rather than from the lysosomes.


Figure 5
View larger version (37K):
[in this window]
[in a new window]

  		FIGURE 5.
Effect of thapsigargin (Tg) on NAADP-mediated Ca2+ signaling in intact Jurkat T-lymphocytes. Jurkat T cells were loaded with Fura-2 and subjected to combined Ca2+ imaging and microinjection as detailed under "Experimental Procedures." All experiments were conducted in the presence of GdCl3 (100 µM) to block capacitative Ca2+ entry. The time points of vehicle (Me2SO (DMSO)) or thapsigargin additions and microinjections are indicated by arrows; the time points of microinjections were synchronized. In A, cells were incubated with vehicle (Me2SO 0.1% v/v) and microinjected with 100 nM NAADP. In B, thapsigargin (in Me2SO) was added twice at 1 µM as indicated. In C, cells were incubated with thapsigargin (in Me2SO) and microinjected with 100 nM NAADP.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Although not confirmed in a great variety of cells, NAADP has been proposed to be an important second messenger in glucose-stimulated pancreatic beta-cells (7), in cholecystokinin-mediated Ca2+ signaling in pancreatic acinar cells (8), and in Ca2+ signaling in Jurkat T cells stimulated via the TCR-CD3 complex (9). Thus, at least in these selected cell types, the NAADP/Ca2+ signaling system may play an important role for cellular function. Therefore, important modules of this signaling system are the target organelle and target Ca2+ channel of NAADP. There has been much debate as to whether NAADP acts on a novel receptor/Ca2+ channel or whether RyRs respond to NAADP directly or indirectly, e.g. via a separate binding protein (reviewed in Ref. 32). For T cells, we recently demonstrated that functional RyR are required for both local and global Ca2+ signals induced by NAADP (20, 21). Although RyR are assumed to be localized at the ER (or SR), suggesting that the NAADP-sensitive Ca2+ pool is located there, convincing data from other cell systems, including sea urchin eggs (10, 11), pancreatic acinar- and beta-cells (33), neurosecretory PC12 cells (34), and guinea pig cardiac myocytes (35), prompted us to investigate involvement of a lysosomal Ca2+ store in NAADP-mediated Ca2+ signaling in T cells. The first approach, lysis of lysosomes using the cathepsin substrate GPN, has successfully been used in sea urchin eggs (11) and pancreatic acinar cells (33); in sea urchin eggs, GPN-mediated bursting of lysosomes selectively abolished Ca2+ signaling by NAADP but not by InsP3 or cADPR (11). This result could not be reproduced in T cells; the Ca2+-mobilizing effects of all three messengers, NAADP, InsP3, or cADPR, were massively reduced. Since bursting of lysosomes is assumed to release proteases and other hydrolases into the cytosol, it is well imaginable that proteolytic attack of the InsP3 receptor or the RyR is the reason for the lack of effect of InsP3 or cADPR. Thus, although the method may work well in other cell types, such as sea urchin eggs, it appears to be not suitable for T cells.

The second approach, bafilomycin A1, yielded an even better loss of staining of the lysosomes in intact Jurkat T cells (compare Fig. 1A with Fig. 2A), indicating that the H+ gradient across the lysosomal membrane was effectively destroyed. Lack of lysosomal staining was almost completed at 25 nM bafilomycin A1. However, NAADP-mediated Ca2+ signaling was not affected by up to 1000 nM bafilomycin A1 in T cells. In contrast, in sea urchin eggs, bafilomycin A1 inhibited Ca2+ release induced by NAADP in experiments where NAADP was liberated from caged NAADP subsequently two times. Interestingly, the Ca2+ release induced by the first uncaging of NAADP was not influenced, whereas the second one was largely reduced (11). Churchill et al. (11) suggested, "that the lysosomal Ca2+ store is replete and non-leaky in resting cells, and that bafilomycin sensitivity is only revealed once the store is mobilized, making its inhibition use-dependent." However, in higher eukaryotic cell types, e.g. in pancreatic acinar cells, bafilomycin A1 inhibited cholecystokinin-induced Ca2+ spiking without prior emptying of stores (33). Similarly, glucose-induced Ca2+ signaling in pancreatic beta-cells (MIN6 cells) was abrogated by bafilomycin A1 (33). Thus, in higher eukaryotic cells, the NAADP-sensitive Ca2+ stores obviously are not very "non-leaky." Consequently, the lack of inhibitory effect of bafilomycin A1 on NAADP-induced Ca2+ signals in T cells (Fig. 2) strongly indicates that the NAADP-sensitive Ca2+ store of T cells is not the lysosomal compartment. To be on the safe side, and assuming that T cells are more similar to sea urchin eggs than to pancreatic cells concerning a non-leaky NAADP-sensitive Ca2+ store, a further crucial experiment was performed (Fig. 4); T cells were first stimulated via the TCR-CD3 complex in the presence of bafilomycin A1, and then NAADP was microinjected. TCR-CD3 stimulation elevates NAADP in a biphasic manner (9), and thus, Ca2+ present in NAADP-sensitive stores was released. Due to the presence of bafilomycin A1, any reuptake of Ca2+ into acidic stores was inhibited. Nevertheless, there was no inhibition of subsequent Ca2+ signaling induced by microinjection of NAADP, ruling out the possibility that T cells possess a very tight (= non-leaky) NAADP-sensitive lysosomal Ca2+ store.


Figure 6
View larger version (29K):
[in this window]
[in a new window]

  		FIGURE 6.
Effect of NAADP on Ca2+ release by thapsigargin (Tg) or GPN in intact Jurkat T-lymphocytes. Jurkat T cells were loaded with Fura-2 and subjected to combined Ca2+ imaging and microinjection as detailed under "Experimental Procedures." All experiments were conducted in the presence of GdCl3 (10 µM) to block capacitative Ca2+ entry. The time points of microinjections and additions of thapsigargin or GPN are indicated by arrows; the time points of thapsigargin or GPN additions were synchronized. After microinjection of 100 nM NAADP or intracellular buffer (IC) as control, thapsigargin (A and B; 1 µM) or GPN (C and D; 50 µM) was added. A quantitative comparison of mean [Ca2+]i at the peak after the addition of thapsigargin or GPN is shown in E; data represent mean values ± S.E. from the time point 400–550 s (mean values and S.E. were calculated from each individual tracing as shown in the overlays).

 
In contrast to the idea that pancreatic acinar cells exclusively possess a lysosomal Ca2+ store sensitive to NAADP, Gerasimenko et al. obtained evidence for NAADP-mediated Ca2+ release from the nuclear envelope (18) and partially from both the ER and acidic organelles (19). In a similar approach in which the activation of capacitative Ca2+ entry was blocked by GdCl3, we emptied ER Ca2+ stores by the addition of thapsigargin. Since subsequent microinjection of NAADP did not induce Ca2+ release in most of the cells investigated, it is very likely that NAADP indeed acts on an endoplasmic reticular Ca2+ store in T cells. In contrast, in the complimentary experiment (prior microinjection of NAADP followed by the addition of thapsigargin), the effect of thapsigargin was reduced as compared with prior microinjection of intracellular buffer (Fig. 6). These data indicate that indeed the filling state of the ER was decreased by approximately 35% by prior injection of NAADP. A similar experiment carried out using GPN instead of thapsigargin to analyze the filling state of the lysosomes resulted in no difference regardless of whether the cells had been microinjected by NAADP or intracellular buffer. Taken together, our results demonstrate a major role for the ER, but not for lysosomes, in NAADP-mediated Ca2+ signaling in T cells.


   FOOTNOTES
 
* This work was supported by the Deutsche Forschungsgemeinschaft Grants GU 360/7-3 and 7-5 (to A. H. G.) and the Gemeinnützige Hertie-Stiftung Grants 1.01.1/04/010 and 1.01.1/07/005 (to A. H. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 Supported by a stipend from the Studienstiftung des Deutschen Volkes. Back

2 To whom correspondence should be addressed. Tel.: 49-40-42803-2828; Fax: 49-40-42803-9880; E-mail: guse{at}uke.uni-hamburg.de.

3 The abbreviations used are: NAADP, nicotinic acid adenine dinucleotide phosphate; GPN, glycyl-phenylalanine 2-naphthylamide; cADPR, cyclic ADP-ribose; InsP3, D-myo-inositol 1,4,5-trisphosphate; RyR, ryanodine receptor(s); TCR-CD3, T cell receptor-CD3 complex; ER, endoplasmic reticulum; SR, sarcoplasmic reticulum; HPLC, high pressure liquid chromatography; RP-HPLC, reverse phase-HPLC. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Lee, H. C., and Aarhus, R. (1995) J. Biol. Chem. 270, 2152–2157[Abstract/Free Full Text]
  2. Guse, A. H., da Silva, C. P., Emmrich, F., Ashamu, G. A., Potter, B. V. L., and Mayr, G. W. (1995) J. Immunol. 155, 3353–3359[Abstract]
  3. Cancela, J. M., Van Coppenolle, F., Galione, A., Tepikin, A. V., and Petersen, O. H. (2002) EMBO J. 21, 909–919[CrossRef][Medline] [Order article via Infotrieve]
  4. Harmer, A. R., Gallacher, D. V., and Smith, P. M. (2001) Biochem. J. 353, 555–560[CrossRef][Medline] [Order article via Infotrieve]
  5. Johnson, J. D., and Misler, A. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 14566–14571[Abstract/Free Full Text]
  6. Berg, I., Potter, B. V. L., Mayr, G. W., and Guse, A. H. (2000) J. Cell Biol. 150, 581–588[Abstract/Free Full Text]
  7. Masgrau, R., Churchill, G. C., Morgan, A. J., Ashcroft, S. J., and Galione, A. (2003) Curr. Biol. 13, 247–251[CrossRef][Medline] [Order article via Infotrieve]
  8. Yamasaki, M., Thomas, J. M., Churchill, G. C., Garnham, C., Lewis, A. M., Cancela, J., Patel, S., and Galione, A. (2005) Curr. Biol. 15, 874–878[CrossRef][Medline] [Order article via Infotrieve]
  9. Gasser, A., Bruhn, S., and Guse, A. H. (2006) J. Biol. Chem. 281, 16906–16913[Abstract/Free Full Text]
  10. Lee, H. C., and Aarhus, R. (2000) J. Cell Sci. 113, 4413–4420[Abstract]
  11. Churchill, G. C., Okada, Y., Thomas, J. M., Genazzani, A. A., Patel, S., and Galione, A. (2002) Cell 111, 703–708[CrossRef][Medline] [Order article via Infotrieve]
  12. Patel, S., Churchill, G. C., and Galione, A. (2000) Biochem. J. 352, 725–729[CrossRef][Medline] [Order article via Infotrieve]
  13. Berridge, G., Dickinson, G., Parrington, J., Galione, A., and Patel, S. (2002) J. Biol. Chem. 277, 43717–43723[Abstract/Free Full Text]
  14. Dickinson, G. D., and Patel, S. (2003) Biochem. J. 375, 805–812[CrossRef][Medline] [Order article via Infotrieve]
  15. Churamani, D., Dickinson, G. D., and Patel, S. (2005) Biochem. J. 386, 497–504[CrossRef][Medline] [Order article via Infotrieve]
  16. Mojzisova, A., Krizanova, O., Zacikova, L., Kominkova, V., and Ondrias, K. (2001) Pfluegers Arch. Eur. J. Physiol. 441, 674–677[CrossRef][Medline] [Order article via Infotrieve]
  17. Hohenegger, M., Suko, J., Gscheidlinger, R., Drobny, H., and Zidar, A. (2002) Biochem. J. 367, 423–431[CrossRef][Medline] [Order article via Infotrieve]
  18. Gerasimenko, J. V., Maruyama, Y., Yano, K., Dolman, N. J., Tepikin, A. V., Petersen, O. H., and Gerasimenko, O. V. (2003) J. Cell Biol. 163, 271–282[Abstract/Free Full Text]
  19. Gerasimenko, J. V., Sherwood, M., Tepikin, A. V., Petersen, O. H., and Gerasimenko, O. V. (2006) J. Cell Sci. 119, 226–238[Abstract/Free Full Text]
  20. Langhorst, M. F., Schwarzmann, N., and Guse, A. H. (2004) Cell. Signal. 16, 1283–1289[CrossRef][Medline] [Order article via Infotrieve]
  21. Dammermann, W., and Guse, A. H. (2005) J. Biol. Chem. 280, 21394–21399[Abstract/Free Full Text]
  22. Guse, A. H., Roth, E., and Emmrich, F. (1993) Biochem. J. 291, 447–451[Medline] [Order article via Infotrieve]
  23. Kunerth, S., Mayr, G. W., Koch-Nolte, F., and Guse, A. H. (2003) Cell. Signal. 15, 783–792[Medline] [Order article via Infotrieve]
  24. Bruzzone, S., Kunerth, S., Zocchi, E., De Flora, A., and Guse, A. H. (2003) J. Cell Biol. 163, 837–845[Abstract/Free Full Text]
  25. Guse, A. H., Berg, I., da Silva, C. P., Potter, B. V. L., and Mayr, G. W. (1997) J. Biol. Chem. 272, 8546–8550[Abstract/Free Full Text]
  26. Sun-Wada, G.-H., Imai-Senga, Y., Yamamoto, A., and Murata, Y. (2006) J. Biol. Chem. 277, 18098–18105
  27. Jadot, M., Comant, C., Wattiaux-de Conick, S., and Wattiaux, R. (1984) Biochem. J. 219, 965–970[Medline] [Order article via Infotrieve]
  28. Docampo, R., and Moreno, S. N. (1999) Parasitol. Today 15, 443–448[CrossRef][Medline] [Order article via Infotrieve]
  29. Thastrup, O., Cullen, P. J., Drobak, B. K., Hanley, M. R., and Dawson, A. P. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2466–2470[Abstract/Free Full Text]
  30. Gouy, H., Cefai, D., Christensen, S. B., Debre, P., and Bismuth, G. (1990) Eur. J. Immunol. 20, 2269–2275[Medline] [Order article via Infotrieve]
  31. Hoth, M., and Penner, R. (1992) Nature 355, 353–356[CrossRef][Medline] [Order article via Infotrieve]
  32. Galione, A., and Petersen, O. (2005) Mol. Interv. 5, 73–79[Abstract/Free Full Text]
  33. Yamasaki, M., Masgrau, R., Morgan, A. J., Churchill, G. C., Patel, S., Ashcroft, S. J., and Galione, A. (2004) J. Biol. Chem. 279, 7234–7240[Abstract/Free Full Text]
  34. Brailoiu, E., Churamani, D,. Pandey, V., Brailoiu, G. C., Tuluc, F., Patel, S., and Dun, N. J. (2006) J. Biol. Chem. 281, 15923–15928[Abstract/Free Full Text]
  35. Macgregor, A., Yamasaki, M., Rakovic, S., Sanders, L., Parkesh, R., Churchill, G. C., Galione, A., and Terrar, D. A. (2007) J. Biol. Chem. 10.1074/jbc.M611167200[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Dammermann, B. Zhang, M. Nebel, C. Cordiglieri, F. Odoardi, T. Kirchberger, N. Kawakami, J. Dowden, F. Schmid, K. Dornmair, et al.
NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist
PNAS, June 30, 2009; 106(26): 10678 - 10683.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
F. Koch-Nolte, F. Haag, A. H. Guse, F. Lund, and M. Ziegler
Emerging Roles of NAD+ and Its Metabolites in Cell Signaling
Sci. Signal., February 10, 2009; 2(57): mr1 - mr1.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
A. H. Guse and H. C. Lee
NAADP: A Universal Ca2+ Trigger
Sci. Signal., November 4, 2008; 1(44): re10 - re10.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/26/18864    most recent
M610925200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steen, M.
Right arrow Articles by Guse, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steen, M.
Right arrow Articles by Guse, A. H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement